| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/28/2000 | EP1013288A2 Erythropoietin in the treatment of domestic and livestock animals for anemia |
| 06/28/2000 | EP1013287A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/28/2000 | EP1013285A2 Urokinase-type plasminogen activator receptor |
| 06/28/2000 | EP1013278A1 The extract of pine needle and the use thereof |
| 06/28/2000 | EP1012303A1 Factor x deletion mutants and analogues thereof |
| 06/28/2000 | EP1012284A1 Mpl ligand analogs |
| 06/28/2000 | EP1012281A2 Human leukocyte calcium activated potassium channel polypeptide |
| 06/28/2000 | EP1012273A2 Secreted proteins and polynucleotides encoding them |
| 06/28/2000 | EP1012262A1 Human frezzled-like protein |
| 06/28/2000 | EP1012191A1 Method for obtaining high-purity vwf or factor viii/vwf complex |
| 06/28/2000 | EP1012172A1 Acylated peptide cytolytic peptide inhibitors |
| 06/28/2000 | EP1012164A1 Serine protease inhibitors |
| 06/28/2000 | EP1012140A1 New amidino derivatives and their use as thrombin inhibitors |
| 06/28/2000 | EP1011743A1 Loading and release of water-insoluble drugs |
| 06/28/2000 | EP1011710A1 Methods and compositions for optimization of oxygen transport by cell-free systems |
| 06/28/2000 | EP1011666A1 Antithrombotic agents |
| 06/28/2000 | EP1011607A2 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 06/28/2000 | EP0557418B1 A beta-type transforming growth factor |
| 06/28/2000 | CN1258218A Mixture of primary fatty acids obtained from sugar can wax and pharmaceutical use thereof |
| 06/28/2000 | CN1257729A Medicine for treating palsy and its preparing process |
| 06/28/2000 | CN1257720A Medicine for treating hypercoagulable blood and its preparing process |
| 06/28/2000 | CN1257718A Cogon grass root-white gourd tea and its preparing process |
| 06/28/2000 | CN1257706A Application of butyl phthalide in preparing medicines curing thrombosis and thrombocyte coagulation |
| 06/28/2000 | CN1053924C Process for preparing CR1 and thrombolytic agent contg. composition |
| 06/27/2000 | US6080767 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 06/27/2000 | US6080538 Plasma like solution and methods of use |
| 06/27/2000 | US6080398 Chemokines modified by truncation of from 2 to 8 amino acids from the amino terminus of the corresponding mature chemokine selected from kc, gro-beta, gro-gamma, and gro-alpha; lower dose needed, less toxicity |
| 06/27/2000 | US6080397 Infusion or surgical rinse colloidal solutions of polyvinylpyrrolidone (pvp) of given molecular weight; free of impurities and high molecular weight pvp, and having low: amine content, peroxide, and solvent; nonallergenic |
| 06/22/2000 | WO2000036105A1 Prostacyclin-stimulating factor-2 |
| 06/22/2000 | WO2000036090A2 Human brain endothelial cells and growth medium and method for expansion of primitive cd34+cd38- bone marrow stem cells |
| 06/22/2000 | WO2000035933A1 Troxerutin with high trihydroxy-ethyl-rutin content and method for preparing same |
| 06/22/2000 | WO2000035886A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors |
| 06/22/2000 | WO2000035885A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors |
| 06/22/2000 | WO2000035869A1 New amidino derivatives and their use as thrombin inhibitors |
| 06/22/2000 | WO2000035859A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
| 06/22/2000 | WO2000035858A1 Phenylglycine derivatives |
| 06/22/2000 | WO2000035483A1 Methods and products for regulating lectin complement pathway associated complement activation |
| 06/22/2000 | WO2000035446A1 Thrombopoietin mimetics |
| 06/22/2000 | WO2000035444A1 USE OF η-TOCOPHEROL AND ITS OXIDATIVE METABOLITE LLU-α IN THE TREATMENT OF DISEASE |
| 06/22/2000 | WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 06/22/2000 | WO2000035428A2 Tricyclic nitrogen heterocycles as pde iv inhibitors |
| 06/22/2000 | WO2000035423A1 Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same |
| 06/22/2000 | WO2000015244A3 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |
| 06/22/2000 | WO2000012504A3 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one |
| 06/22/2000 | WO2000012018A9 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers or covering structures |
| 06/22/2000 | WO2000011033A3 Expression and export of angiostatin and endostatin as immunofusins |
| 06/22/2000 | CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 06/22/2000 | CA2355864A1 Thrombopoietin mimetics |
| 06/22/2000 | CA2355363A1 Prostacyclin-stimulating factor-2 |
| 06/22/2000 | CA2355249A1 Protease inhibitors |
| 06/22/2000 | CA2353924A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors |
| 06/22/2000 | CA2353561A1 Human brain endothelial cells and growth medium and method for expansion of primitive cd34+cd38- bone marrow stem cells |
| 06/22/2000 | CA2353151A1 Substituted aryl and heteroaryl derivatives, the preparation thereof and their use as medicaments |
| 06/22/2000 | CA2345752A1 Tricyclic nitrogen heterocycles as pde iv inhibitors |
| 06/21/2000 | EP1009831A2 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
| 06/21/2000 | EP1009765A1 EPO PRIMARY RESPONSE GENE, EPRG3Spt |
| 06/21/2000 | EP1009738A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 06/21/2000 | EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 06/21/2000 | EP1009730A1 New pentaerythritol derivatives, their production and use and intermediates for their synthesis |
| 06/21/2000 | EP1009417A1 Dietary supplements containing natural ingredients |
| 06/21/2000 | EP0205564B2 Method for the production of erythropoietin |
| 06/21/2000 | DE19858331A1 Tricyclische Stickstoffheterocyclen als PDE IV Inhibitoren Tricyclic nitrogen heterocycles as PDE IV inhibitors |
| 06/21/2000 | DE19856443A1 Stabilisiertes Antithrombin III-Präparat Stabilized antithrombin III preparation |
| 06/21/2000 | DE19851294C1 Ischämie/reperfusionsinduzierbare DNAs und Proteine Ischemia / reperfusionsinduzierbare DNAs and proteins |
| 06/21/2000 | CN1257538A Short peptides which selectively modulate the activity of serine/threonine kinases |
| 06/21/2000 | CN1257429A Use of low-molecular-weight heparins for preventing and treating cerebral edemas |
| 06/21/2000 | CN1256919A Shuanggan injection and preparation process thereof |
| 06/21/2000 | CN1256918A Application of lotucine in pharmacy |
| 06/21/2000 | CN1053653C Novel L-threonic acid derivant |
| 06/21/2000 | CN1053581C Yunnan Baiyao (white drug-powder) tablet and preparation method thereof |
| 06/20/2000 | US6077857 Heterocyclic compounds containing two amide groups which have hemoregulatory activities, can be used to stimulate hematopoiesis and for the treatment of viral, fungal and bacterial infections |
| 06/20/2000 | US6077855 Hemoregulatory compounds |
| 06/20/2000 | US6077828 Method for the prevention and treatment of cachexia and anorexia |
| 06/20/2000 | US6077659 Treating erythrocyte/photosensitizer composition with vitamin e, alpha-tocopherol phosphate, alpha-tocopherol succinate, or 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid |
| 06/20/2000 | US6077507 Method of making a composition comprising a fibrin monomer |
| 06/20/2000 | CA2215659C Morphinan hydroxamic acid compounds |
| 06/20/2000 | CA1341032C Anticoagulant peptides |
| 06/20/2000 | CA1341029C Peptidase inhibitors |
| 06/15/2000 | WO2000034515A1 Use of factor x polymorphism in the diagnosis and treatment of factor x and/or factor xa mediated diseases |
| 06/15/2000 | WO2000034505A1 Expression system for factor viii |
| 06/15/2000 | WO2000034468A2 Muc-1 antagonists and methods of treating immune disorders |
| 06/15/2000 | WO2000034283A1 Novel triazolo(4,5-d)pyrimidine compounds |
| 06/15/2000 | WO2000034258A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group |
| 06/15/2000 | WO2000034236A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE |
| 06/15/2000 | WO2000033894A1 Collagen hemostatic foam |
| 06/15/2000 | WO2000033893A1 Sterile complex of therapeutic peptide bond to a polysaccharide |
| 06/15/2000 | WO2000033867A1 Method of treating thrombocytopenic purpura and hemolytic uremic syndrome |
| 06/15/2000 | WO2000033851A1 Peritoneal dialysis solution containing modified icodextrins |
| 06/15/2000 | WO2000033850A1 Remedies for hyperammonemia |
| 06/15/2000 | WO2000033847A1 Micronized eplerenone compositions |
| 06/15/2000 | WO2000033844A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
| 06/15/2000 | WO2000033838A1 Vitronectin receptor antagonist |
| 06/15/2000 | WO2000033828A1 Agent for lowering endothelin levels |
| 06/15/2000 | WO2000033822A1 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof |
| 06/15/2000 | WO2000033817A1 Phospholipid compositions |
| 06/15/2000 | WO1999058098A3 HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO |
| 06/15/2000 | DE19856668A1 Wirkstoffmatrix in Form eines biologisch resorbierbaren porösen Vlieses, Verfahren zu ihrer Herstellung und Verwendung Active substance matrix in the form of a biologically resorbable porous nonwoven, methods for their preparation and use |
| 06/15/2000 | CA2354644A1 Muc-1 antagonists and methods of treating immune disorders |
| 06/15/2000 | CA2354142A1 Reversible aqueous ph sensitive lipidizing reagents, compositions and methods of use |
| 06/15/2000 | CA2354040A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |